{"id":"https://openalex.org/W2010590441","doi":"https://doi.org/10.1002/1097-0142(197607)38:1<13::aid-cncr2820380104>3.0.co;2-5","title":"Combination chemotherapy and adriamycin in patients with advanced breast cancer.A Southwest Oncology Group study","display_name":"Combination chemotherapy and adriamycin in patients with advanced breast cancer.A Southwest Oncology Group study","publication_year":1976,"publication_date":"1976-07-01","ids":{"openalex":"https://openalex.org/W2010590441","doi":"https://doi.org/10.1002/1097-0142(197607)38:1<13::aid-cncr2820380104>3.0.co;2-5","mag":"2010590441","pmid":"https://pubmed.ncbi.nlm.nih.gov/947510"},"language":"en","primary_location":{"id":"doi:10.1002/1097-0142(197607)38:1<13::aid-cncr2820380104>3.0.co;2-5","doi":"https://doi.org/10.1002/1097-0142(197607)38:1<13::aid-cncr2820380104>3.0.co;2-5","is_oa":true,"landing_page_url":"https://doi.org/10.1002/1097-0142(197607)38:1<13::aid-cncr2820380104>3.0.co;2-5","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/1097-0142%28197607%2938%3A1%3C13%3A%3AAID-CNCR2820380104%3E3.0.CO%3B2-5","source":{"id":"https://openalex.org/S126033908","display_name":"Cancer","issn_l":"0008-543X","issn":["0008-543X","1045-7410","1097-0142"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/1097-0142%28197607%2938%3A1%3C13%3A%3AAID-CNCR2820380104%3E3.0.CO%3B2-5","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5033453413","display_name":"Barth Hoogstraten","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210128618","display_name":"University of Kansas Medical Center","ror":"https://ror.org/036c9yv20","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210128618"]},{"id":"https://openalex.org/I4210165553","display_name":"SWOG Cancer Research Network","ror":"https://ror.org/05n6zrm60","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884","https://openalex.org/I4210165553"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"B. Hoogstraten","raw_affiliation_strings":["American Cancer Society Professor of Clinical Oncology, The University of Kansas Medical Center, Kansas City, Kansas","Chairman, Southwest Oncology Group, 3500 Rainbow Blvd., Suite 201, Kansas City, KS 66103"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"American Cancer Society Professor of Clinical Oncology, The University of Kansas Medical Center, Kansas City, Kansas","institution_ids":["https://openalex.org/I4210128618"]},{"raw_affiliation_string":"Chairman, Southwest Oncology Group, 3500 Rainbow Blvd., Suite 201, Kansas City, KS 66103","institution_ids":["https://openalex.org/I4210165553"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007275246","display_name":"Stephen L. George","orcid":"https://orcid.org/0000-0002-3625-5852","observed_orcids":["https://orcid.org/0000-0002-3625-5852"]},"institutions":[{"id":"https://openalex.org/I4210124801","display_name":"European Organisation for Research and Treatment of Cancer","ror":"https://ror.org/034wxcc35","country_code":"BE","type":"nonprofit","lineage":["https://openalex.org/I4210124801"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"S. L. George","raw_affiliation_strings":["Director, EORTC Data Center, Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Director, EORTC Data Center, Brussels, Belgium","institution_ids":["https://openalex.org/I4210124801"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108905531","display_name":"B. Samal","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I185443292","display_name":"Wayne State University","ror":"https://ror.org/01070mq45","country_code":"US","type":"education","lineage":["https://openalex.org/I185443292"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"B. Samal","raw_affiliation_strings":["Assistant Professor of Medicine, Wayne State University School of Medicine, Detroit, Michigan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Assistant Professor of Medicine, Wayne State University School of Medicine, Detroit, Michigan","institution_ids":["https://openalex.org/I185443292"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077337021","display_name":"Saul E. Rivkin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210093417","display_name":"Swedish Medical Center","ror":"https://ror.org/004jktf35","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210093417","https://openalex.org/I94396219"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. E. Rivkin","raw_affiliation_strings":["The Tumor Institute of the Swedish Hospital, Seattle, Washington"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Tumor Institute of the Swedish Hospital, Seattle, Washington","institution_ids":["https://openalex.org/I4210093417"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108444709","display_name":"J J Costanzi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I55302922","display_name":"The University of Texas Medical Branch at Galveston","ror":"https://ror.org/016tfm930","country_code":"US","type":"education","lineage":["https://openalex.org/I55302922"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. J. Costanzi","raw_affiliation_strings":["Associate Professor of Medicine, University of Texas Medical Branch, Galveston, Texas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Associate Professor of Medicine, University of Texas Medical Branch, Galveston, Texas","institution_ids":["https://openalex.org/I55302922"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036980145","display_name":"John D. Bonnet","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210102330","display_name":"Baylor Scott & White Medical Center - Temple","ror":"https://ror.org/017cm6884","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210102330","https://openalex.org/I4210160418"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. D. Bonnet","raw_affiliation_strings":["Director, Section of Hematology-Oncology, Scott and White Clinic, Temple, Texas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Director, Section of Hematology-Oncology, Scott and White Clinic, Temple, Texas","institution_ids":["https://openalex.org/I4210102330"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111540401","display_name":"Tate Thigpen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I368840534","display_name":"University of Mississippi","ror":"https://ror.org/02teq1165","country_code":"US","type":"education","lineage":["https://openalex.org/I368840534","https://openalex.org/I4210141039"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"T. Thigpen","raw_affiliation_strings":["Assistant Professor of Medicine, University of Mississippi, Jackson, Mississippi"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Assistant Professor of Medicine, University of Mississippi, Jackson, Mississippi","institution_ids":["https://openalex.org/I368840534"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110094699","display_name":"H. Braine","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1289568071","display_name":"Brooke Army Medical Center","ror":"https://ror.org/00m1mwc36","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289568071","https://openalex.org/I1330347796","https://openalex.org/I2800250139","https://openalex.org/I2800386880"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"H. Braine","raw_affiliation_strings":["Brooke Army Medical Center, Fort Sam Houston, Texas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Brooke Army Medical Center, Fort Sam Houston, Texas","institution_ids":["https://openalex.org/I1289568071"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":9,"corresponding_author_ids":["https://openalex.org/A5033453413"],"corresponding_institution_ids":["https://openalex.org/I4210128618","https://openalex.org/I4210165553"],"apc_list":{"value":4790,"currency":"USD","value_usd":4790},"apc_paid":null,"fwci":3.4644,"has_fulltext":true,"cited_by_count":150,"citation_normalized_percentile":{"value":0.93345009,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":94},"biblio":{"volume":"38","issue":"1","first_page":"13","last_page":"20"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.98580002784729,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.98580002784729,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.010400000028312206,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/advanced-breast-cancer","display_name":"advanced breast cancer","score":0.9959999918937683},{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":0.9049999713897705},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.9860000014305115},{"id":"https://openalex.org/keywords/cyclophosphamide","display_name":"cyclophosphamide","score":0.8799999952316284},{"id":"https://openalex.org/keywords/methotrexate","display_name":"methotrexate","score":0.9980000257492065},{"id":"https://openalex.org/keywords/5-fluorouracil","display_name":"5-fluorouracil","score":0.9990000128746033},{"id":"https://openalex.org/keywords/vincristine","display_name":"vincristine","score":0.9580000042915344},{"id":"https://openalex.org/keywords/prednisone","display_name":"prednisone","score":0.9950000047683716},{"id":"https://openalex.org/keywords/weekly-chemotherapy","display_name":"weekly chemotherapy","score":0.4749999940395355},{"id":"https://openalex.org/keywords/intermittent-chemotherapy","display_name":"intermittent chemotherapy","score":0.9449999928474426},{"id":"https://openalex.org/keywords/response-rate","display_name":"response rate","score":0.6399999856948853},{"id":"https://openalex.org/keywords/duration-of-response","display_name":"duration of response","score":0.9900000095367432},{"id":"https://openalex.org/keywords/leukopenia","display_name":"leukopenia","score":0.9449999928474426},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.8519999980926514}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9547175168991089},{"id":"https://openalex.org/C2780873365","wikidata":"https://www.wikidata.org/wiki/Q496812","display_name":"Leukopenia","level":3,"score":0.7794487476348877},{"id":"https://openalex.org/C2779429289","wikidata":"https://www.wikidata.org/wiki/Q408977","display_name":"Vincristine","level":4,"score":0.7245245575904846},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.7203225493431091},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.6782798767089844},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6438217163085938},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6075274348258972},{"id":"https://openalex.org/C3019864225","wikidata":"https://www.wikidata.org/wiki/Q5867482","display_name":"Combination chemotherapy","level":3,"score":0.5242998003959656},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5159209966659546},{"id":"https://openalex.org/C2781059491","wikidata":"https://www.wikidata.org/wiki/Q422232","display_name":"Methotrexate","level":2,"score":0.49709251523017883},{"id":"https://openalex.org/C2778720950","wikidata":"https://www.wikidata.org/wiki/Q424972","display_name":"Prednisone","level":2,"score":0.43671634793281555},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.41387292742729187},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.36430567502975464}],"mesh":[{"descriptor_ui":"D000505","descriptor_name":"Alopecia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004341","descriptor_name":"Drug Evaluation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006321","descriptor_name":"Heart","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007970","descriptor_name":"Leukopenia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D008727","descriptor_name":"Methotrexate","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011241","descriptor_name":"Prednisone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014750","descriptor_name":"Vincristine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014839","descriptor_name":"Vomiting","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1002/1097-0142(197607)38:1<13::aid-cncr2820380104>3.0.co;2-5","doi":"https://doi.org/10.1002/1097-0142(197607)38:1<13::aid-cncr2820380104>3.0.co;2-5","is_oa":true,"landing_page_url":"https://doi.org/10.1002/1097-0142(197607)38:1<13::aid-cncr2820380104>3.0.co;2-5","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/1097-0142%28197607%2938%3A1%3C13%3A%3AAID-CNCR2820380104%3E3.0.CO%3B2-5","source":{"id":"https://openalex.org/S126033908","display_name":"Cancer","issn_l":"0008-543X","issn":["0008-543X","1045-7410","1097-0142"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"journal-article"},{"id":"pmid:947510","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/947510","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"Clinical Trial"}],"best_oa_location":{"id":"doi:10.1002/1097-0142(197607)38:1<13::aid-cncr2820380104>3.0.co;2-5","doi":"https://doi.org/10.1002/1097-0142(197607)38:1<13::aid-cncr2820380104>3.0.co;2-5","is_oa":true,"landing_page_url":"https://doi.org/10.1002/1097-0142(197607)38:1<13::aid-cncr2820380104>3.0.co;2-5","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/1097-0142%28197607%2938%3A1%3C13%3A%3AAID-CNCR2820380104%3E3.0.CO%3B2-5","source":{"id":"https://openalex.org/S126033908","display_name":"Cancer","issn_l":"0008-543X","issn":["0008-543X","1045-7410","1097-0142"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2010590441.pdf","grobid_xml":"https://content.openalex.org/works/W2010590441.grobid-xml"},"referenced_works_count":8,"referenced_works":["https://openalex.org/W129917815","https://openalex.org/W1980574892","https://openalex.org/W2024841231","https://openalex.org/W2025639667","https://openalex.org/W2073636635","https://openalex.org/W2092015388","https://openalex.org/W4241085754","https://openalex.org/W4241431800"],"related_works":["https://openalex.org/W1991488226","https://openalex.org/W1985997571","https://openalex.org/W1983087619","https://openalex.org/W2079487121","https://openalex.org/W2463158456","https://openalex.org/W2085493687","https://openalex.org/W2069294464","https://openalex.org/W2052281493","https://openalex.org/W137190526","https://openalex.org/W2050319891"],"abstract_inverted_index":{"In":[0],"January,":[1],"1972,":[2],"the":[3,78,82,122,133],"Southwest":[4],"Oncology":[5],"Group":[6],"initiated":[7],"two":[8],"randomized":[9],"studies":[10],"for":[11,19,33,106,111,118,137],"patients":[12,20,34,138],"with":[13,21,29,125,139],"advanced":[14,140],"breast":[15],"cancer.":[16],"The":[17,31,98,129],"study":[18,32],"prior":[22],"chemotherapy":[23,37],"showed":[24],"a":[25,43,71],"33%":[26],"response":[27,83,102],"rate":[28],"adriamycin.":[30,119],"without":[35],"previous":[36],"consisted":[38],"of":[39,47,61,101,144],"three":[40,127],"treatment":[41],"regimens;":[42],"weekly":[44,86,107,130],"repeated":[45,64],"combination":[46,87,91,131],"cyclophosphamide,":[48],"methotrexate,":[49],"5-fluorouracil,":[50],"vincristine,":[51],"and":[52,68,94,114],"prednisone;":[53],"these":[54],"same":[55],"five":[56],"drugs":[57],"given":[58],"in":[59],"courses":[60],"5":[62],"days":[63],"every":[65,74],"4":[66,116],"weeks;":[67],"adriamycin":[69,95,148],"as":[70],"single":[72],"agent":[73],"3":[75],"weeks.":[76],"For":[77],"283":[79],"evaluable":[80],"patients,":[81],"rates":[84],"were:":[85],"63/106":[88],"(59%);":[89],"intermittent":[90,112],"39/98":[92],"(40%);":[93],"31/79":[96],"(39%).":[97],"median":[99],"duration":[100],"was":[103,121],"8":[104],"months":[105,110,117],"combination,":[108],"10":[109],"therapy":[113,136],"only":[115],"Leukopenia":[120],"dose-limiting":[123],"toxicity":[124],"all":[126],"regimens.":[128],"is":[132],"most":[134],"effective":[135],"disease.":[141],"Extensive":[142],"trails":[143],"combinations":[145],"that":[146],"include":[147],"are":[149],"underway.":[150]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}